Clinical drug development costs have increased ten-fold over a decade; however, the productivity of the industry continues to decline. For neurodegenerative conditions like Parkinson disease, clinical trials are increasingly large, long, and expensive, yet trials continue to be plagued by high failure rates. Novel approaches are, therefore, required. New research methods including disease modeling and simulation, and new technologies that enable remote participation in research studies and objective measurement of disease, such as smartphones and sensors, can help evaluate therapeutics more efficiently. However, these methods and technologies have had limited application in Parkinson disease studies to date. A laboratory to develop, evaluate and disseminate these and other new approaches to research can help advance the field. In this application, we outline the development of the administrative infrastructure, collaborative partnerships, and research capabilities necessary to construct such a laboratory. This proposal addresses many of the recommendations outlined in NINDS's Parkinson's Disease 2014: Advancing Research, Improving Lives, and will develop into a valuable Morris K. Udall Center of Excellence to serve as a unique resource for other Udall Centers and the greater Parkinson disease community.
This exploratory grant will develop, evaluate and disseminate new methods and technologies to advance therapeutic development for Parkinson disease. Our vision is that these new approaches, which include simulation models, remote assessments, and objective measures of disease, will modernize Parkinson disease clinical research and enable anyone anywhere with Parkinson disease to engage in research, benefit from therapeutic advances, and receive care.
|Badawy, Reham; Raykov, Yordan P; Evers, Luc J W et al. (2018) Automated Quality Control for Sensor Based Symptom Measurement Performed Outside the Lab. Sensors (Basel) 18:|
|Dorsey, E Ray; Yvonne Chan, Yu-Feng; McConnell, Michael V et al. (2017) The Use of Smartphones for Health Research. Acad Med 92:157-160|
|Latourelle, Jeanne C; Beste, Michael T; Hadzi, Tiffany C et al. (2017) Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation. Lancet Neurol 16:908-916|
|Dorsey, E Ray; Topol, Eric J (2016) State of Telehealth. N Engl J Med 375:1400|
|Dorsey, E Ray; Vlaanderen, Floris P; Engelen, Lucien Jlpg et al. (2016) Moving Parkinson care to the home. Mov Disord 31:1258-62|
|Augustine, Erika F; Dorsey, E Ray; Hauser, Robert A et al. (2016) Communicating with participants during the conduct of multi-center clinical trials. Clin Trials 13:592-596|
|Bot, Brian M; Suver, Christine; Neto, Elias Chaibub et al. (2016) The mPower study, Parkinson disease mobile data collected using ResearchKit. Sci Data 3:160011|
|Espay, Alberto J; Bonato, Paolo; Nahab, Fatta B et al. (2016) Technology in Parkinson's disease: Challenges and opportunities. Mov Disord 31:1272-82|
|Venuto, Charles S; Potter, Nicholas B; Dorsey, E Ray et al. (2016) A review of disease progression models of Parkinson's disease and applications in clinical trials. Mov Disord 31:947-956|
|Dorsey, E Ray; Venuto, Charles; Venkataraman, Vinayak et al. (2015) Novel methods and technologies for 21st-century clinical trials: a review. JAMA Neurol 72:582-8|